Multiple Myeloma Clinical Trial

Efficacy of a Patient Education Video

Summary

Patients in the intervention arm will view the 23-minute video depicting the Hematopoietic stem cell transplantation (HSCT) experience. Patients in the control arm will receive HSCT frequently asked questions (FAQ) sheet developed by the National Cancer Institute (NCI) at the National Institutes of Health (NIH).

View Full Description

Full Description

The study's overall goals are 1) to improve outcomes; and 2) to increase satisfaction with the physician consultation.

Patients will be randomized to intervention or control and data will be collected at three time points (before treatment, 30 days post-HSCT and 12 months post-HSCT).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Cancer patients scheduled for HSCT

Exclusion Criteria:

Patients who have received HSCT previously
Patients who do not speak English

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

9

Study ID:

NCT02114827

Recruitment Status:

Terminated

Sponsor:

Virginia Commonwealth University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Virginia Commonwealth University
Richmond Virginia, 23298, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

9

Study ID:

NCT02114827

Recruitment Status:

Terminated

Sponsor:


Virginia Commonwealth University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider